RxDoctor Payments DataLook up a doctor →

Guillermo Deangulo

Pediatric Hematology-Oncology · Miami, FLNPI 1679791370

Payments from drug & device makers

$992,123in general payments, 2019–2025

Across 624 payments — averaging $1589.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$218K
  • United Therapeutics Corporation$215K
  • Jazz Pharmaceuticals Inc.$176K
  • Amgen$145K
  • Servier Pharmaceuticals LLC$75K
  • Bioverativ Therapeutics Inc.$61K
  • plus $102K from 25 others
$4,216in research payments, 2019–2025

Across 4 payments — averaging $1053.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Octapharma USA, Inc.$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$992,123 in reported general payments places this provider in the 95th percentile of 132 pediatric hematology-oncology providers in Florida.

See all pediatric hematology-oncology providers in Florida

Other pediatric hematology-oncology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →